Eli Lilly Co Drug Patent Portfolio

Eli Lilly Co's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Authorities in Gurgaon confiscated a fake weight loss drug valued at Rs 56 lakh from a taxi, with a primary suspect involved.

20 Apr, 2026

Eli Lilly is reportedly in advanced negotiations to purchase Kelonia Therapeutics for more than $2 billion, according to the Wall Street Journal.

19 Apr, 2026

This Pharmaceutical Company Has Outperformed the S&P 500 in the Past Ten Years - The Globe and Mail

18 Apr, 2026

US appellate court reinstates Teva's lawsuit against Eli Lilly regarding migraine medication.

17 Apr, 2026